Ongoing Research : Interest in peptides and their various applications continues to grow, with efforts underway to develop more amino acid combinations that replicate the effects of BPC and other peptides 1
GHK-Cu extends the anagen phase, meaning each follicle spends more time actively producing hair
During this meeting, the advisory committee will: Review available safety and efficacy data for BPC-157, including preclinical studies and any available clinical evidence Consider public comments submitted by patients, practitioners, and industry stakeholders Evaluate the clinical need for compounded BPC-157 and the patient populations that would benefit Assess the compounding quality considerations specific to peptide formulations Issue a recommendation to the FDA on whether BPC-157 should be included on the 503A compounding list Possible outcomes include: Positive recommendation: PCAC advises the FDA to add BPC-157 to the 503A list, clearing the way for legal compounding nationwide
Filip A, Taleb S, Bascetin R, Jahangiri M, Bardin M, Lerognon C
